AU Patent

AU2006286497A1 — Use of an aureolysin inhibitor for the treatment of inflammatory skin conditions characterised by colonisation with Staphylococcus aureus

Assigned to Serentis Ltd · Expires 2007-03-08 · 19y expired

What this patent protects

Patent listed against Temovate.

Drugs covered by this patent

Patent Metadata

Patent number
AU2006286497A1
Jurisdiction
AU
Classification
—
Expires
2007-03-08
Drug substance claim
No
Drug product claim
No
Assignee
Serentis Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.